Applied Therapeutics Future Growth
Future criteria checks 6/6
Applied Therapeutics is forecast to grow earnings and revenue by 81.9% and 43.6% per annum respectively. EPS is expected to grow by 72% per annum. Return on equity is forecast to be 252.2% in 3 years.
Key information
81.9%
Earnings growth rate
72.0%
EPS growth rate
| Biotechs earnings growth | 21.3% |
| Revenue growth rate | 43.6% |
| Future return on equity | 252.2% |
| Analyst coverage | Low |
| Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
Feb 16Is Applied Therapeutics (NASDAQ:APLT) In A Good Position To Deliver On Growth Plans?
Feb 16
Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
Nov 13We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
Aug 11We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
May 19Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
Jan 19Is Applied Therapeutics (NASDAQ:APLT) Using Debt In A Risky Way?
Nov 11Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
Aug 13Applied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorder
Jun 17Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
May 15Independent Director Stacy Kanter Just Bought 100% More Shares In Applied Therapeutics, Inc. (NASDAQ:APLT)
Feb 26How Much Of Applied Therapeutics, Inc. (NASDAQ:APLT) Do Insiders Own?
Feb 18Applied Therapeutics to resume galactosemia study for AT-007
Feb 02Applied Therapeutics, Inc. (NASDAQ:APLT) Insiders Have Been Selling
Nov 24
Applied Therapeutics EPS misses by $0.21
Nov 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 131 | 42 | 73 | 73 | 3 |
| 12/31/2025 | 68 | -20 | -39 | -39 | 5 |
| 12/31/2024 | 9 | -73 | -81 | -81 | 4 |
| 12/31/2023 | 10 | -120 | -55 | -55 | N/A |
| 9/30/2023 | 11 | -97 | -54 | -54 | N/A |
| 6/30/2023 | 11 | -73 | -59 | -59 | N/A |
| 3/31/2023 | 11 | -70 | -61 | -61 | N/A |
| 12/31/2022 | N/A | -83 | -78 | -78 | N/A |
| 9/30/2022 | N/A | -95 | -89 | -89 | N/A |
| 6/30/2022 | N/A | -105 | -85 | -85 | N/A |
| 3/31/2022 | N/A | -105 | -93 | -93 | N/A |
| 12/31/2021 | N/A | -106 | -91 | -91 | N/A |
| 9/30/2021 | N/A | -102 | -87 | -87 | N/A |
| 6/30/2021 | N/A | -104 | -92 | -92 | N/A |
| 3/31/2021 | N/A | -106 | -82 | -82 | N/A |
| 12/31/2020 | N/A | -94 | -78 | -78 | N/A |
| 9/30/2020 | N/A | -88 | -68 | -68 | N/A |
| 6/30/2020 | N/A | -69 | -55 | -55 | N/A |
| 3/31/2020 | N/A | -49 | -48 | -48 | N/A |
| 12/31/2019 | N/A | -46 | -36 | -36 | N/A |
| 9/30/2019 | N/A | -35 | -30 | -30 | N/A |
| 6/30/2019 | N/A | -28 | -24 | -24 | N/A |
| 3/31/2019 | N/A | -23 | -17 | -17 | N/A |
| 12/31/2018 | N/A | -17 | -11 | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APLT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: APLT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: APLT is expected to become profitable in the next 3 years.
Revenue vs Market: APLT's revenue (43.6% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: APLT's revenue (43.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: APLT's Return on Equity is forecast to be very high in 3 years time (252.2%).